Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Tuberculosis re-treatment after exclusion of rifampicin resistance

Chen-Yuan Chiang, Arnaud Trébucq
European Respiratory Journal 2018 51: 1702282; DOI: 10.1183/13993003.02282-2017
Chen-Yuan Chiang
1International Union Against Tuberculosis and Lung Disease, Paris, France
2Division of Pulmonary Medicine, Dept of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
3Division of Pulmonary Medicine, Dept of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cychiang@theunion.org
Arnaud Trébucq
1International Union Against Tuberculosis and Lung Disease, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 51 no. 2
DOI 
https://doi.org/10.1183/13993003.02282-2017
PubMed 
29444921

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received November 3, 2017
  • Accepted December 4, 2017
  • Published online February 14, 2018.

Copyright & Usage 
Copyright ©ERS 2018

Author Information

  1. Chen-Yuan Chiang1,2,3⇑ and
  2. Arnaud Trébucq1
  1. 1International Union Against Tuberculosis and Lung Disease, Paris, France
  2. 2Division of Pulmonary Medicine, Dept of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
  3. 3Division of Pulmonary Medicine, Dept of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
  1. Chen-Yuan Chiang, 111 Hsin-Long Road, Section 3, Taipei, 116, Taiwan. E-mail: cychiang{at}theunion.org
View Full Text

Article usage

Article usage: February 2018 to April 2022

AbstractFullPdf
Feb 20181981913
Mar 20182362931
Apr 2018861217
May 201898318
Jun 201892218
Jul 201859121
Aug 2018791143
Sep 201856423
Oct 201883541
Nov 2018781042
Dec 201887330
Jan 2019811036
Feb 201955619
Mar 201985634
Apr 201937315
May 201932014
Jun 201940019
Jul 201977245
Aug 2019261252
Sep 201911174
Oct 2019012128
Nov 201902592
Dec 201911996
Jan 2020130116
Feb 2020137110
Mar 2020017111
Apr 2020110236
May 202001167
Jun 202001138
Jul 20200128
Aug 202001155
Sep 202002284
Oct 202001487
Nov 2020124111
Dec 2020425114
Jan 20210889
Feb 20210776
Mar 2021119101
Apr 2021128112
May 2021253114
Jun 2021118136
Jul 202111181
Aug 202121586
Sep 2021017100
Oct 2021015126
Nov 2021018146
Dec 2021125113
Jan 202213289
Feb 202202366
Mar 202214481
Apr 202224399

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 51 Issue 2 Table of Contents
European Respiratory Journal: 51 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tuberculosis re-treatment after exclusion of rifampicin resistance
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Tuberculosis re-treatment after exclusion of rifampicin resistance
Chen-Yuan Chiang, Arnaud Trébucq
European Respiratory Journal Feb 2018, 51 (2) 1702282; DOI: 10.1183/13993003.02282-2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Tuberculosis re-treatment after exclusion of rifampicin resistance
Chen-Yuan Chiang, Arnaud Trébucq
European Respiratory Journal Feb 2018, 51 (2) 1702282; DOI: 10.1183/13993003.02282-2017
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Rifapentine access in Europe: concerns over key TB treatment
  • P. aeruginosa membrane vesicles cause endothelial barrier failure
  • Mortality after admission with pneumonia higher than after admission with COPD exacerbation
Show more Agora

Correspondence

  • Extracorporeal life support as a bridge to lung transplantation strategy in anti-MDA5+ rapidly progressive interstitial lung disease is life-saving but with persistent difficulties at the bedside
  • Liver cancer in severe alpha-1 antitrypsin deficiency: Who is at risk?
  • Cancer risk in severe alpha-1-antitrypsin deficiency - the importance of the early identification
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society